Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 29.12
+0.14 (0.48%)
Apr 17, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.81 billion as of April 17, 2026. Its market cap has increased by 104.09% in one year.
Market Cap
11.81B
Enterprise Value
12.00B
Revenue
704.16M
Ranking
n/a
PE Ratio
530.74
Stock Price
29.12
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.81B, a decrease of -26.94%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 11.81B | 14.76% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 13.06B |
| Chengzhi | 12.88B |
| InventisBio | 12.30B |
| Pacific Shuanglin Bio-pharmacy | 12.16B |
| Hualan Biological Vaccine | 12.06B |
| Chongqing Genrix Biopharmaceutical | 11.73B |
| Chengdu Easton Biopharmaceuticals | 11.66B |
| Aurisco Pharmaceutical | 11.56B |